Who is sponsoring NCT05140967?

NCT05140967 is sponsored by University of Kiel.

What drugs are being tested in NCT05140967?

Interventions in NCT05140967: High Intensity Interval Training (HIIT), Moderate Continuous Intensity Training (MICT).

What condition does NCT05140967 study?

NCT05140967 studies Cystic Fibrosis.

Is NCT05140967 still recruiting?

NCT05140967 is currently completed. Last updated 17 February 2025.

Last reviewed 2025-02-17 · How we verify

NCT05140967

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis

Completed NA Last updated 17 February 2025

What this trial tests

NA trial testing High Intensity Interval Training (HIIT) in Cystic Fibrosis in 70 participants. Completed in 31 December 2024.

Timeline

15 October 2021

Primary endpoint
31 December 2023

31 December 2024

Quick facts

Lead sponsor	University of Kiel
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	15 October 2021
Primary completion	31 December 2023
Estimated completion	31 December 2024
Sites	2 locations across Germany

Drugs / interventions tested

High Intensity Interval Training (HIIT)
Moderate Continuous Intensity Training (MICT)

Conditions studied

Cystic Fibrosis — all drugs for Cystic Fibrosis →

Sponsor

University of Kiel

Who can join

Adults 18 to 70, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the randomized controlled trial is to investigate the effects of endurance training with different intensities on physical performance, body composition and appetite regulation in people with cystic fibrosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor/Tezacaftor/Ivacaftor Therapy.
Koop J, Gruber W, Hägele FA, Norman K, et al · · 2025 · PMID 40806025 · DOI 10.3390/nu17152439

Verify or expand the search:

Other trials of High Intensity Interval Training (HIIT)

Trials testing the same drug.

NCT06831266 — Effects of Exercise Prediabetic Individuals · NA · recruiting
NCT06551441 — Cardiopulmonary Adaptations to High-intensity Interval Training (HIIT) in COPD · NA · recruiting
NCT06609954 — "COMPARATIVE EFFECTS of REDUCED EXERTION HIGH INTENSITY TRAINING (REHIT) VERSUS HIGH INTENSITY INTERVAL TRAINING (HIIT) · NA · active not recruiting
NCT06610006 — Combined Effects of Isometric Wall Squats and High Intensity Interval Training on Rate Pressure Product in Normotensive · NA · active not recruiting
NCT06059872 — Biomarkers of Reaction To HIIT Exercise · NA · recruiting

Other recruiting trials for Cystic Fibrosis

Currently open trials in the same condition.

NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting

Other University of Kiel trials

Trials by the same sponsor.

NCT07141719 — Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker · not yet recruiting
NCT07105787 — Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna · NA · recruiting
NCT06498349 — Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl · NA · recruiting
NCT07058285 — Steps Against the Burden of Parkinson's Disease - RCT Kiel · NA · recruiting
NCT04316390 — Influence of Hesperidin and Vitamin C on Uric Acid Concentration · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05140967 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kiel
Last refreshed: 17 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05140967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing